Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis

John P. Fitzgerald, Barbara Ercole, Dipen J. Parekh

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

The basis of treatment for advanced germ cell tumors is chemotherapy and surgical resection of residual disease. Surgery has maintained its role in staging and therapeutic management. Despite these advances, much of the outcomes depend on proper patient selection. Complete removal of all post-chemotherapy residual masses remains the standard of care in the treatment of advanced nonseminomatous germ cell tumors both within and outside of the retroperitoneum.

Original languageEnglish (US)
Pages (from-to)98-101
Number of pages4
JournalIndian Journal of Urology
Volume26
Issue number1
DOIs
StatePublished - Jan 1 2010
Externally publishedYes

Keywords

  • Cancer
  • Testis

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis'. Together they form a unique fingerprint.

  • Cite this